分類: 技術轉移招商
Technology Available for Industry-Academia Collaboration or Technology Licensing. “Characterizing molecular and clinical features in hepatopancreatobiliary cancers”
Technology Available for Industry-Academia Collaboration or Technology Licensing. “Characterizing molecular and clinical features in hepatopancreatobiliary cancers” Date: 2026.07.13 Title: NHRI technology, “Characterizing molecular and clinical …
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR901: a Humanized HSP90a Antibody with Anti-Desmoplasia Potency” (2022/11/18)
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR901: a Humanized HSP90a Antibody with Anti-Desmoplasia Potency” Date: 2022.11.18 1. Title: NHRI technology, “DBPR901: a …
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR22998: IsoQC inhibitor targeting CD47-SIRPa “Do not eat me” cancer immune checkpoint” (2022/11/18)
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR22998: IsoQC inhibitor targeting CD47-SIRPa “Do not eat me” cancer immune checkpoint” Date: 2022.11.18 1. Title: …
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR807: A CXCR4-Targeted Antagonist” (2022/7/26)
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR807: A CXCR4-Targeted Antagonist” Date: 2022.7.26 1. Title: NHRI technology, “DBPR807: A CXCR4-Targeted Antagonist” (abbreviated as “The …
Technology Available for Industry-Academia Collaboration or Technology Licensing. “An Aurora kinase inhibitor for precision targeting of MYC-amplified cancers” (2022/01/03)
1. Title: NHRI technology, “An Aurora kinase inhibitor for precision targeting of MYC-amplified cancers” (abbreviated as “The Technology”) available for industry-academia collaboration or technology licensing. …
